Sort
50,496 grants matching “lung cancer”
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$657,955Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2019 · CA
Beyond Binding: Personalized Multi-omic Neoantigen Identification
$657,934Rachel Karchin · Johns Hopkins University · R01 · FY2025 · CA
Phenotype Transitions in Small Cell Lung Cancer
$657,892Vito Quaranta · Vanderbilt University · U01 · FY2019 · CA
Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA
$657,845Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Image guided intervention system for pancreatic cystic lesions
$657,842Nicusor Iftimia · Physical Sciences, Inc · R44 · FY2011 · CA
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
$657,837Debra L Friedman · Vanderbilt University Medical Center · R01 · FY2021 · CA
PREMIERE: A PREdictive Model Index and Exchange REpository
$657,823Alex Bui · University Of California Los Angeles · R01 · FY2019 · EB
Phenotypic marker-guided development of selective antimetastasis therapeutic leads
$657,810Sui Huang · Northwestern University At Chicago · R01 · FY2022 · CA
Multi-cellular interactions defining the human brain metastatic niche
$657,805Benjamin Izar · Columbia University Health Sciences · R01 · FY2024 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$657,791Cheryl A London · Tufts University Boston · U01 · FY2023 · CA
Highly tumor-selective pan RAS inactivators for targeting oncogenic RAS-driven cancers
$657,776Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Personalized Task-Based Respiratory Motion Correction for Low-Dose PET/CT
$657,758Chi Liu · Yale University · R01 · FY2018 · CA
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
$657,652Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials
$657,592Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2021 · CA
Lung Cancer Screening: Cumulative Risk and Multilevel Impact of False Positive Findings
$657,536Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
$657,412Mark David Pagel · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
$657,403Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2024 · CA
CXCL12 signaling axis in pulmonary arterial heterogeneity, development, and disease
$657,308David Brian Frank · Children'S Hosp Of Philadelphia · R56 · FY2023 · HL
Clinical Translation of a Choline-targeted NIR dye to guide lung cancer resection
$657,168Edward J Delikatny · University Of Pennsylvania · R01 · FY2025 · CA
Clinical Laboratory Core
$657,163Jennifer W Tidey · Brown University · P20 · FY2021 · GM
Assessing genome sequence integrity in normal human cells
$657,078Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U01 · FY2019 · ES
Assessing genome sequence integrity in normal human cells
$657,078Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U01 · FY2021 · ES
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$657,074Lan Zhou · Methodist Hospital Research Institute · R01 · FY2025 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$657,066James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Clinical trials employing cancer vaccine combination therapies
$657,066James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA